Autolus Therapeutics plc ( AUTL) - Stock Earnings
AUTL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -90.2 million USD | 24.3 million USD |
| 2026Q1 | -71.6 million USD | 26.2 million USD |
| 2026Q2 | -39.1 million USD | 45.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AUTL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -208.4 million USD | 1.7 million USD |
| 2024 | -220.7 million USD | 10.1 million USD |
| 2025 | -288.2 million USD | 75.6 million USD |
| 2026 Est. | — | — |
AUTL
Price: $1.79
52 week price:
Earnings Per Share: -1.13 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 412700
Market Capitalization: 596.2 million